Citadel Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Buy
+19,600
New +$436K ﹤0.01% 9836
2025
Q4
Sell
-48,600
Closed -$1.17M 12527
2025
Q3
$1.17M Buy
48,600
+25,300
+109% +$591K ﹤0.01% 7191
2025
Q2
$453K Sell
23,300
-21,300
-48% -$315K ﹤0.01% 8873
2025
Q1
$574K Sell
44,600
-13,200
-23% -$212K ﹤0.01% 8182
2024
Q4
$996K Buy
57,800
+31,100
+116% +$622K ﹤0.01% 7029
2024
Q3
$603K Buy
26,700
+14,200
+114% +$325K ﹤0.01% 7866
2024
Q2
$309K Buy
12,500
+3,300
+36% +$93.7K ﹤0.01% 9077
2024
Q1
$303K Sell
9,200
-500
-5% -$17K ﹤0.01% 9433
2023
Q4
$353K Sell
9,700
-2,800
-22% -$96.1K ﹤0.01% 8822
2023
Q3
$459K Sell
12,500
-6,300
-34% -$251K ﹤0.01% 8242
2023
Q2
$720K Sell
18,800
-200
-1% -$7.39K ﹤0.01% 7129
2023
Q1
$778K Sell
19,000
-42,900
-69% -$1.79M ﹤0.01% 7339
2022
Q4
$2.15M Buy
61,900
+21,800
+54% +$762K ﹤0.01% 5337
2022
Q3
$1.11M Buy
40,100
+14,600
+57% +$474K ﹤0.01% 6762
2022
Q2
$756K Sell
25,500
-24,600
-49% -$827K ﹤0.01% 7673
2022
Q1
$2.04M Buy
50,100
+13,900
+38% +$597K ﹤0.01% 6047
2021
Q4
$1.73M Sell
36,200
-42,800
-54% -$1.92M ﹤0.01% 6582
2021
Q3
$3.27M Sell
79,000
-25,800
-25% -$1.03M ﹤0.01% 5171
2021
Q2
$4.74M Sell
104,800
-18,600
-15% -$870K ﹤0.01% 4567
2021
Q1
$5.45M Sell
123,400
-7,100
-5% -$268K ﹤0.01% 4067
2020
Q4
$4.54M Buy
130,500
+24,400
+23% +$688K ﹤0.01% 3856
2020
Q3
$1.84M Buy
106,100
+2,900
+3% +$50.5K ﹤0.01% 4869
2020
Q2
$1.7M Sell
103,200
-94,900
-48% -$1.44M ﹤0.01% 4861
2020
Q1
$1.8M Sell
198,100
-122,800
-38% -$2.47M ﹤0.01% 4321
2019
Q4
$6.82M Sell
320,900
-184,700
-37% -$4.1M ﹤0.01% 2680
2019
Q3
$11.6M Buy
505,600
+124,200
+33% +$2.83M 0.01% 2047
2019
Q2
$9.26M Buy
381,400
+282,800
+287% +$5.82M ﹤0.01% 2267
2019
Q1
$1.28M Buy
98,600
+35,700
+57% +$625K ﹤0.01% 5168
2018
Q4
$947K Sell
62,900
-33,800
-35% -$874K ﹤0.01% 5397
2018
Q3
$3.8M Buy
96,700
+51,000
+112% +$2.3M ﹤0.01% 3364
2018
Q2
$2.25M Buy
45,700
+7,600
+20% +$431K ﹤0.01% 3925
2018
Q1
$2.28M Buy
38,100
+11,100
+41% +$740K ﹤0.01% 3531
2017
Q4
$2.13M Buy
27,000
+4,000
+17% +$323K ﹤0.01% 3555
2017
Q3
$1.93M Sell
23,000
-4,600
-17% -$326K ﹤0.01% 3451
2017
Q2
$1.8M Buy
27,600
+14,300
+108% +$973K ﹤0.01% 3307
2017
Q1
$967K Buy
13,300
+7,900
+146% +$519K ﹤0.01% 4046
2016
Q4
$316K Buy
+5,400
New +$285K ﹤0.01% 5595

Other funds holding ADNT

Citadel Advisors's ADNT Position: Q1 2026 in Review

Citadel Advisors reduced its Adient (ADNT) stake by 15% in Q1 2026, selling an estimated $1.32M and leaving 336,037 shares worth $6.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

Citadel Advisors first reported a position in ADNT in Q4 2016 and has held it in 33 quarters since. The position peaked at $78.5M in Q1 2023. 286 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Citadel Advisors held 336,037 shares of Adient worth $6.79M as of Q1 2026.
  • Citadel Advisors sold 59,417 Adient shares in Q1 2026, an estimated $1.32M.
  • Adient made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3854 holding.
  • Citadel Advisors first reported a position in Adient in Q4 2016 and has held it in 33 quarters since.
  • Citadel Advisors's Adient position peaked at $78.5M in Q1 2023.
  • 286 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.